Y4 SELECTIVE RECEPTOR AGONIST FOR THERAPEUTIC INTERVENTIONS

摘要

The use of a Y receptor agonist which is selective for the Y4 receptor over the Y1 and Y2 receptors, said Y receptor agonist comprising residues 2-36 of Pancreatic Polypeptide (PP) in the preparation of a composition for treatment of conditions responsive to activation of Y4 receptors.